UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Oriental medicine practitioners hit record high in 2017
The number of Oriental medicine practitioners in the healthcare sector hit ...
by Lee Min-ju
|
2019-03-05 14:23
라인
World’s 5th gastrointestinal endoscopy conference to kick off in Korea
The Korean Society of Gastrointestinal Endoscopy (KSGE) has organized the w...
by By Kim Yun-mi
|
2019-03-04 18:08
라인
Hanmi releases P4 clinical trials for anti-hypertension treatment
Hanmi Pharmaceutical said Monday that it has published the results of phase...
by Lee Han-soo
|
2019-03-04 17:01
라인
Minister Park calls for ‘closer international cooperation for patient safety’
Minister of Health and Welfare Park Neung-hu expressed an intention to help...
by Song Soo-youn
|
2019-03-04 17:00
라인
Regulator expands XGEVA’s indication for use by multiple myeloma patients
Amgen’s XGEVA (denosumab), a treatment for reducing possibilities of skelet...
by Kim Yun-mi
|
2019-03-04 16:02
라인
AbbVie gets positive views for treatment of plaque psoriasis in EU
AbbVie said Monday that the European Medicines Agency's Committee for M...
by Lee Han-soo
|
2019-03-04 15:57
라인
‘Korea’s biopharma sector has sufficient potential’
A recognized “bio expert” has recently become the director-general of the B...
by Lee Hye-seon
|
2019-03-04 14:44
라인
Roche Diagnostic Korea names new general manager
Johnny Tse has begun serving as the general manager of the Korean offshoot ...
by Lee Han-soo
|
2019-03-04 14:16
라인
Qurient unveils P2a trial results for atopic dermatitis treatment in US
Qurient said Monday that it has presented the phase 2a clinical trial resul...
by Lee Han-soo
|
2019-03-04 14:16
라인
US trade agency begins probe into Medytox’s complaint about Daewoong
Medytox said Monday that the U.S. International Trade Commission has starte...
by Lee Han-soo
|
2019-03-04 11:16
라인
Bridge Biotherapeutics to accelerate global presence
Lee Jung-kue, CEO of Bridge Biotherapeutics, is making noticeable strides i...
by Lee Han-soo
|
2019-03-04 10:50
라인
Doctors, medical students struggled for Korea’s independence from Japanese colonialists
This year marks the 100th anniversary of the March 1 Independence Movement,...
by Lee Han-soo
|
2019-03-01 07:36
라인
BioGenetics inks deal to supply biliary tract cancer drug in Korea
BioGenetics said it has signed a deal with Singapore-based drugmaker Aslan ...
by Lee Hye-seon
|
2019-02-28 16:49
라인
Hospitals still force new residents to pay ‘entry fee’
Hospitals are still forcing trainee physicians to pay a large amount of cas...
by Song Soo-youn
|
2019-02-28 16:47
라인
GC starts P1 trials of hemophilia treatment
GC said Thursday that it has administered the first dose of MG1113, a hemop...
by Lee Han-soo
|
2019-02-28 16:45
라인
Bukwang to sell Novartis’ chronic hepatitis B treatment
Bukwang Pharmaceutical said Thursday that it has just begun domestic market...
by Lee Han-soo
|
2019-02-28 14:59
라인
‘Nurses were independence fighters during March 1 Movement’
On Friday this week, the nation marks the 100th anniversary of the March 1 ...
by Lee Min-ju
|
2019-02-28 14:58
라인
Chong Kun Dang topped clinical trials in 2018
Local drugmaker Chong Kun Dang won approval for clinical trials the most am...
by Lee Hye-seon
|
2019-02-28 10:50
라인
Korea, China to cooperate for regulations on drugs, medical devices, cosmetics
Korea and China agreed to strengthen cooperation for regulations on pharmac...
by Lee Hye-seon
|
2019-02-27 22:41
라인
Korea’s 30th novel drug K-Cab to get insurance benefit from March
Korea’s 30th novel medicine K-Cab Tab. (ingredient: tegoprazan) will receiv...
by Lee Hye-seon
|
2019-02-27 16:47
-
이전
141
142
143
144
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top